Kalkine has a fully transformed New Avatar.
Company Overview: Tronox Holdings Plc (NYSE: TROX) is involved in the mining, exploration and marketing of titanium products. The company also manufactures electrolytic manganese dioxide, primarily focused on specialty boron products and battery materials. TROX is also involved in manufacturing pigments for paints and other plastics, coatings, and paper for applications in inks, rubber, food, fibres, pharmaceuticals, and cosmetics.
TROX Details
Material Business Updates
Historical Financial Trend:
TROX illustrated sustainable historical growth while keeping the value proposition intact. The Operating revenues have been growing since FY16 with consistent growth in gross income. Operating revenues grew at a 20.5% CAGR (FY16 – FY20), above the industry estimates.
Figure 1: Historical Financial Overview
Source: Company Reports, Analysis by Kalkine Group
First Quarter FY21 Performance:
TROX recorded a 14% sequential increase in revenue, primarily resulting from double-digit growth in zircon and TiO2 volumes and a 3% surge in TiO2 average sale price. Adjusted EBITDA remains ahead of the guidance with a 25% margin, predominantly driven by improved revenues and partially offset by unfavourable FX impact.
On the balance sheet front, liquidity position stays resilient with modifications in debt structure to mitigate interest burden. As a result, the net debt to TTM Adjusted EBITDA ratio stood at 3.8x, and free cash flow levels for the quarter stood at US$77 million.
Figure 2: Quarterly Performance (1QFY21)
Source: Company Reports, Analysis by Kalkine Group
Full-Year FY20 Performance:
Revenue increased marginally by 4% due to improved TiO2 sales volumes in South and Central America, followed by Europe, North America and EMEA. As a result of pension curtailment gain and release of tax valuation allowances, net income surged exponentially, partially offsetted by transaction costs attached to TTI acquisitions, integration and restructuring costs. Despite significant improvements in bottom-line, cash flows from operating activities declined by ~13.8%, predominantly affected by ~US$899 million adjustments in deferred income taxes.
Figure 3: Annual Performance (FY20)
Source: Company Reports, Analysis by Kalkine Group
Top 10 Shareholders:
The top 10 shareholders together form ~56.70% of the total shareholding. The Cristal Inorganic Chemicals Netherlands Cooperatief W.A. and Fidelity Management & Research Company LLC holds a maximum stake in the company at ~24.52% and ~7.88%, respectively.
Figure 4: Top 10 Shareholders
Source: Analysis by Kalkine Group
Key Metrics:
Consistent growth in sales volume across zircon and TiO2 has translated into long-term sustainable growth levels. In addition, gross margins improved sequentially with improved operational efficiency. As a result, TROX’ profitability and returns status remain stable and growing despite recent market disruptions.
Figure 5: Key Financial Metrics
Source: Analysis by Kalkine Group
Outlook:
Key Risks:
Amidst global operations, TROX is susceptible to heavy losses from unfavourable FX movements. Moreover, the COVID-19 impact may directly affect product demand and commodity prices which may increase uncertainties.
Valuation Methodology: EV/EBITDA Multiple Based Relative Valuation (Illustrative)
Stock Recommendation: TROX has delivered 3-month and 6-month returns of ~+4.945% and ~+40.446%, respectively. The stock is trading above the average of the 52-week high price of US$24.81 and the 52-week low price of US$6.66, indicating a trending opportunity. We have valued the stock using the EV/EBITDA multiple-based illustrative relative valuation method and have arrived at a target price of low double digit-upside. We believe that the stock might trade at a premium compared to its peer average EV/EBITDA (NTM trading multiple), considering stable operating revenue, refinancing facilities at disposal, and proliferated product demand. For this purpose, we have taken peers such as Chemours Co (NYSE: CC), Kronos Worldwide Inc (NYSE: KRO), Celanese Corp (NYSE: CE), to name a few. Considering the optimized liquidity position, favourable product sales and price, potential strategic acquisition, restructured capital structure, and valuation, we give a “Buy” recommendation on the stock at the current market price of US$20.80, up by ~2.82% on 12 July 2021.
TROX Daily Technical Chart
Source: REFINITIV, Note: The purple color line reflects RSI (14-period) trend.
Note 1: The reference data in this report has been partly sourced from REFINITIV
Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.
Technical Indicators Defined: -
Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.
Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.